Research criteria for the diagnosis of prodromal dementia with Lewy bodies
The prodromal phase of dementia with Lewy bodies (DLB) includes (1) mild cognitive
impairment (MCI),(2) delirium-onset, and (3) psychiatric-onset presentations. The purpose of …
impairment (MCI),(2) delirium-onset, and (3) psychiatric-onset presentations. The purpose of …
Dementia with Lewy bodies: an update and outlook
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder
producing progressive cognitive decline that interferes with normal life and daily activities …
producing progressive cognitive decline that interferes with normal life and daily activities …
[HTML][HTML] The relationship between stress and Alzheimer's disease
NJ Justice - Neurobiology of stress, 2018 - Elsevier
Stress is critically involved in the development and progression of disease. From the stress
of undergoing treatments to facing your own mortality, the physiological processes that …
of undergoing treatments to facing your own mortality, the physiological processes that …
Dementia with Lewy bodies
Dementia with Lewy bodies (DLB) is the second commonest cause of neurodegenerative
dementia in older people. It is part of the range of clinical presentations that share a neuritic …
dementia in older people. It is part of the range of clinical presentations that share a neuritic …
Differentiating dementia disease subtypes with gait analysis: feasibility of wearable sensors?
Background There are unique signatures of gait impairments in different dementia disease
subtypes, such as Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and …
subtypes, such as Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and …
The impact of environment on gait assessment: considerations from real-world gait analysis in dementia subtypes
Laboratory-based gait assessments are indicative of clinical outcomes (eg, disease
identification). Real-world gait may be more sensitive to clinical outcomes, as impairments …
identification). Real-world gait may be more sensitive to clinical outcomes, as impairments …
Plasma biomarkers of neurodegeneration in mild cognitive impairment with Lewy bodies
BackgroundBlood biomarkers of Alzheimer's disease (AD) may allow for the early detection
of AD pathology in mild cognitive impairment (MCI) due to AD (MCI-AD) and as a co …
of AD pathology in mild cognitive impairment (MCI) due to AD (MCI-AD) and as a co …
Computational studies applied to flavonoids against Alzheimer's and Parkinson's diseases
AFM Monteiro, JDO Viana, A Nayarisseri… - Oxidative medicine …, 2018 - Wiley Online Library
Neurodegenerative diseases, such as Parkinson's and Alzheimer's, are understood as
occurring through genetic, cellular, and multifactor pathophysiological mechanisms. Several …
occurring through genetic, cellular, and multifactor pathophysiological mechanisms. Several …
[HTML][HTML] Diagnostic criteria for dementia with Lewy bodies: updates and future directions
M Yamada, J Komatsu, K Nakamura… - Journal of movement …, 2020 - ncbi.nlm.nih.gov
The aim of this article is to describe the 2017 revised consensus criteria for the clinical
diagnosis of dementia with Lewy bodies (DLB) with future directions for the diagnostic …
diagnosis of dementia with Lewy bodies (DLB) with future directions for the diagnostic …
Leisure activity participation and risk of dementia: An 18-year follow-up of the Whitehall II Study
Objective To test the hypothesis that leisure activity participation is associated with lower
dementia risk, we examined the association between participation in leisure activities and …
dementia risk, we examined the association between participation in leisure activities and …